文献速递脑血管病

脑淀粉样血管病急性卒中血管内治疗结局

Endovascular Treatment for Acute Stroke in Cerebral Amyloid Angiopathy.
PubMed 文献 · Stroke · 2021-08-20

基于德国卒中登记血管内治疗队列,162例急性缺血性卒中接受血管内取栓患者中28例(17.3%)经铁敏感MRI诊断CAA。CAA患者90天良好结局比例较低(14.3% vs 37.8%),CAA为独立不良预后预测因素(aOR 0.28,P=0.049)。

要点

  • CAA患者取栓后90天良好结局比例低于非CAA患者(14.3% vs 37.8%)。
  • CAA是取栓后90天不良结局的独立预测因素(aOR 0.28,P=0.049)。
  • CAA患者中静脉溶栓与良好结局率升高相关(36.3% vs 0%,P=0.031)。

核心结论

  • 伴可能或很可能CAA的急性缺血性卒中患者接受血管内取栓(联合或不联合溶栓)似乎获益,但与更差的功能结局相关。

研究设计与样本

  • 观察性多中心队列研究,数据来自德国卒中登记血管内治疗试验(NCT03356392)。
  • 纳入162例急性缺血性卒中接受血管内取栓患者,其中28例(17.3%)基于改良Boston标准诊断可能或很可能CAA。
  • CAA诊断依据为血管内取栓前完成的铁敏感磁共振成像。

主要发现

  • CAA患者90天良好结局比例为14.3%,非CAA患者为37.8%。
  • NIHSS评分(aOR 0.88,P<0.001)、成功再通(aOR 6.82,P=0.005)和CAA(aOR 0.28,P=0.049)为独立结局预测因素。
  • CAA患者中静脉溶栓与良好结局率升高相关(36.3% vs 0%,P=0.031)。

临床怎么用

  • 对伴可能或很可能CAA的急性缺血性卒中患者,血管内取栓联合或不联合溶栓仍可考虑,但需告知功能结局可能更差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: We aimed to compare outcome of endovascular thrombectomy in acute ischemic stroke in patients with and without cerebral amyloid angiopathy (CAA). METHODS: We included patients with and without possible or probable CAA based on the modified Boston criteria from an observational multicenter cohort of patients with acute ischemic stroke and endovascular thrombectomy, the German Stroke Registry Endovascular Treatment trial. We analyzed baseline characteristics, procedural parameters, and functional outcome after 90 days. RESULTS: Twenty-eight (17.3%) of 162 acute ischemic stroke patients were diagnosed with CAA based on iron-sensitive magnetic resonance imaging performed before endovascular thrombectomy. CAA patients were less likely to have a good 90-day outcome (14.3 versus 37.8%). National Institutes of Health Stroke Scale score (adjusted odds ratio, 0.88; P<0.001), successful recanalization (adjusted odds ratio 6.82; P=0.005), and CAA (adjusted odds ratio 0.28; P=0.049) were independent outcome predictors. Intravenous thrombolysis was associated with an increased rate of good outcome (36.3% versus 0%, P=0.031) in CAA. CONCLUSIONS: Endovascular thrombectomy with or without thrombolysis appears beneficial in acute ischemic stroke patients with possible or probable CAA, but is associated with a worse functional outcome. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03356392.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Weller JM, Enkirch SJ, Bogs C, et al. Endovascular Treatment for Acute Stroke in Cerebral Amyloid Angiopathy. Stroke. 2021. PMID: 34412512. doi:10.1161/STROKEAHA.120.033014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。